Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, is pleased to announce it has begun cultivating Psilocybe mushrooms, for the purpose of psilocybin production, at its 7000 square-foot Health Canada…
Last week, Compass Pathways (CMPS) commenced trading on the Nasdaq and became the first psychedelic drug company to go public on a major U.S. stock exchange. When Compass filed to go public, the deal generated substantially more interest from investors than expected. As a result, the psychedelic therapy company upsized…
2020 has been a challenging year for the global economy and the COVID pandemic has made an impact on the mental health market. We believe that the pandemic has served as a catalyst for the psychedelic therapy market as healthcare providers and researchers seek new ways to treat debilitating mental…
Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on a best efforts basis, including the exercise of the agent's option in its entirety in the form of units of the Company (each, a "Unit"). A…
Today, we are lucky to have Doug Drysdale - CEO - of Cybin Corp. with us and appreciate you taking the time to educate our readers. Cybin is a leading Life Sciences Company focused on the development of products and protocols in the psychedelic, pharmaceutical and nutraceutical sectors. Congratulations on…
AWAKN Life Sciences Inc ("AWAKN"), the European psychedelic assisted psychotherapy company, today announces the launch of its Commercial Clinical Research Division. AWAKN's purpose is broadening access to psychedelic assisted psychotherapy and integrating these services into mainstream mental healthcare in Europe across three business divisions of Clinical Research, Therapeutic Clinics, and…
Apotheca Systems Inc., an applied AI for evidence based natural medicines company with an emphasis on AI assistance for cannabis and psychedelic based therapy, is pleased to announce the next development phase of its patent pending AI Assisted Personalized Therapy Framework Platform, Apotheca.ai. With the promise of psychedelic medicine moving…
2020 has been a banner year for the psychedelic sector and we believe that the industry is in the early stages of a major growth cycle. Last week, Compass Pathways announced a major milestone and filed to go public on the Nasdaq Global Market under the symbol CMPS. The leading…
The psychedelic therapy market is an emerging industry that is not even in the first inning of a major growth cycle and there are several companies already working to bring breakthrough therapies for a range of mental health conditions to market. 2020 has been a banner year for the psychedelic…
In a new research study that will greatly expand knowledge of the real-world uses and effects of psychedelic mushrooms (Psilocybin), the nonprofit research organization Unlimited Sciences is collaborating with Johns Hopkins University Center for Psychedelic and Consciousness Research to conduct a survey of people from across the globe, in hopes…
